Article info

Download PDFPDF

Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery
Free

Authors

  • B Prendergast aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, bClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK PubMed articlesGoogle scholar articles
  • D E Newby aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, bClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK PubMed articlesGoogle scholar articles
  • L E Wilson aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, bClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK PubMed articlesGoogle scholar articles
  • D J Webb aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, bClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK PubMed articlesGoogle scholar articles
  • P S Mankad aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, bClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK PubMed articlesGoogle scholar articles
  1. Dr Newby. email: D.E.Newby{at}ed.ac.uk
View Full Text

Citation

Prendergast B, Newby DE, Wilson LE, et al
Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery

Publication history

  • Accepted April 19, 1999
  • First published October 1, 1999.
Online issue publication 
October 01, 1999

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.